Connect with us

There Are Hidden Dangers of Taking Anti-Anxiety Drugs

You’re probably familiar with the benzodiazepines diazepam (Valium), lorazepam (Ativan) and alprazolam (Xanax). They’re among the…

Published

on

You’re probably familiar with the benzodiazepines diazepam (Valium), lorazepam (Ativan) and alprazolam (Xanax). They’re among the most popular drugs worldwide, prescribed most often for generalized anxiety and panic attacks. Xanax has become the fourth most widely prescribed drug in the United States, and it’s no surprise. In a nation where anxiety is as prevalent as the common cold, these medications do their job.

 

But there is a dark side — many dark sides — that should make you think twice before hopping on the benzo bandwagon. These drugs can be used safely, but the decision to take them shouldn’t be entered into lightly.

How do benzodiazepines work?

Benzodiazepines stimulate the brain’s receptors for a chemical called gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter impacting anxiety, mood, sleep and pain sensitivity. The various benzodiazepines differ primarily in how fast and how long they act.

What are the side effects?

They can decrease your ability to think clearly, impair memory and reduce your ability to respond to emergency situations that may arise (for example, if you are driving a car or operating a dangerous piece of machinery).

 

These effects can be seen even in the lowest doses that are usually prescribed. In addition, a recent study found that the use of one of these drugs for at least three months increases your risk of Alzheimer’s disease by 50 percent.

In high doses, benzodiazepines can cause life-threatening respiratory suppression or result in a coma. Since 2000, the number of emergency-room visits due to benzo use has doubled. When combined with narcotics, the risk and severity of these side effects is significantly increased.

Are these drugs habit-forming?

Yes. Their continued use downregulates the brain’s sensitivity to GABA, so not only will you need more of the drug to get the same benefit over time, your baseline state of anxiety without the drug actually increases.

It can be very difficult to get off benzos once you’ve started them, and stopping can come with serious withdrawal symptoms. Insomnia, irritability, heightened anxiety, panic and restlessness are among the most common symptoms. More patients now end up in detox for the combined use of benzodiazepines and opioids than for all alcohol-related complications.

Can you use these drugs safely? Are there alternatives?

Benzos can be effective in relieving an acute panic attack or preventing one in a high-risk situation. However, there are almost always better alternatives. Selective serotonin reuptake inhibitors (SSRIs) like sertaline (Zoloft) and escitalopram (Lexapro) and selective norepinephrine reuptake inhibitors (SNRIs) like venlafaxine (Effexor) and duloxetine (Cymbalta) are the first choice in managing generalized chronic anxiety in those patients who require medication.

 

In the long run, getting to the root of the problem through cognitive behavioral therapy (CBT), counseling and modifying your lifestyle to fortify your defenses against anxiety (getting proper sleep, optimizing nutrition and avoiding caffeine and alcohol) can have a cumulative effect that can lessen or even eliminate your need for these drugs.

Applying skills learned in CBT or using deep-breathing exercises or visualizations (there are many mobile apps that make this convenient) can abort many panic attacks before they become unmanageable. And the more you practice and use these skills, the more effective they become.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Beauty

What a Dark Edge Around an Old Silver Filling Means

Published

on

By

A dark line around an old silver filling is common, and it does not by itself mean the filling has failed. The discoloration usually comes from the metal reacting slowly with saliva at the edge, a different process than new decay forming beneath it.

Why the Metal Darkens at the Margin

Amalgam blends silver, tin, copper and a mercury into a filling material that hardens inside the tooth. Over years of chewing and contact with saliva, the outer edge of that metal can tarnish and pick up a gray or black tint, much the way silverware darkens with age. That surface change happens on its own and does not necessarily mean the seal between the filling and the tooth has broken.

What matters is whether the tooth underneath the filling has stayed intact. A tarnished edge on a filling that still fits tightly is a cosmetic detail. A tarnished edge next to a soft spot, a gap, or a rough ridge is a different situation. A dentist needs to look at it directly, not guess from the color alone.

How Long an Amalgam Filling Is Supposed to Last

Silver fillings often last many years, and how long one holds up depends on its size, the bite on that tooth and daily care. A filling in a molar that takes heavy chewing pressure every day may wear differently than one in a tooth that does less work. Age alone does not tell a dentist whether a filling still fits the tooth the way it did on day one.

That same review lists a few concrete signs to watch for beyond color. A rough or sharp edge you can feel with your tongue, food that keeps catching at the same spot, or a filling that feels loose when you bite down. Those point to an actual change in the material itself, not just its surface.

Why the Color Alone Rarely Settles It

Dentists are generally cautious about pulling out a filling that is otherwise doing its job. One patient guide to fillings notes that dentists are advised against replacing a filling for appearance alone. Removing sound filling material usually means removing some healthy tooth structure along with it. A dark edge, on its own, is cosmetic. Replacing a filling that still seals the tooth trades one small issue for a larger one: a bigger hole to refill.

This is why an exam matters more than a mirror. A dentist checks the margin with an explorer to feel for a ledge or a gap. Then an x-ray shows whether decay has started to form in the layer between the metal and the tooth, something a dark line on the surface cannot show on its own.

What the X-ray Actually Decides

An x-ray of an old filling is looking for one thing: a shadow at the margin where the seal has opened. That gap is where bacteria get underneath the metal and decay starts to spread, invisible from the surface. If the image is clean and the filling still feels solid, it can usually stay in place, color and all, until it is due for its next routine check. A gap or dark area spreading under the metal is what leads to a new filling or a crown. The stain by itself usually does not.

It is reasonable to let a stained, intact filling wait for your next scheduled cleaning. Call sooner if the tooth has started catching food in a new way, or if a rough edge has appeared where there wasn’t one before. The same goes for pressure or sensitivity when you bite down on that side.

When a Filling Is Actually Replaced

Once decay or a broken seal shows up on the x-ray, the tooth usually needs more than a patch. Depending on how much of the tooth is still sound, a dentist may place a new filling or recommend a crown that covers and protects what is left of the tooth structure. That decision is made case by case, after the dentist has seen what the x-ray shows underneath the metal.

For a family practice handling that kind of exam day to day, this is routine work. Smiles By Design, a general dentistry practice in Heber City, Utah, lists general dental appointments, including the exams and x-rays behind decisions like this one, on its services page at smilesbydesignutah.com.

The Decision That Actually Needs Making

A dark edge on an old silver filling is worth mentioning at your next cleaning. It rarely calls for an emergency visit on its own. The tooth underneath, confirmed by an x-ray rather than a guess, is what decides whether that filling stays or gets replaced.

Continue Reading

Health

The Laboratory Report That Looks Complete Until Someone Checks the Sample: Why Independent Testing, Lot Identification and Analytical Limits Matter in Peptide Research Copy headline

Published

on

By

The Laboratory Report That Looks Complete Until Someone Checks the Sample: Why Independent Testing, Lot Identification and Analytical Limits Matter in Peptide Research Copy headline

A laboratory report can look convincing long before anyone has established what it actually proves. A company name appears at the top, a test date sits beneath a sample identifier, and a chromatogram ends with an impressive purity figure. The document may be genuine. The analysis may have been performed correctly. Yet the report can still leave a serious question unanswered: does the result describe the material that eventually reached the research bench?

That distinction matters in peptide research, where material identity, analytical purity and experimental reproducibility depend on different kinds of evidence. An independent test can provide valuable information about a sample, but it cannot repair missing records, confirm an undocumented connection between batches or establish properties that were never measured.

The problem is not necessarily dishonest reporting. Sometimes the report is accurate and the documentation surrounding it is incomplete. Understanding that difference is essential for laboratories reviewing unfamiliar research materials.

What independent testing actually establishes

Independent analytical testing generally involves sending a sample to a laboratory that operates separately from the material’s seller or distributor. The laboratory receives the sample, records identifying information, performs the requested analysis and issues findings associated with that sample.

The separation is valuable. It allows an outside analytical organization to produce measurements rather than leaving all reported results under the direct control of the company supplying the material.

However, independence does not automatically establish the quality of every part of the process. A laboratory may be independent yet receive incomplete sample information. It may use a suitable method to answer one analytical question while another important characteristic remains untested.

Consider a peptide sample submitted for chromatographic analysis. The resulting report may describe the relative distribution of detected components under defined conditions. That information can be useful when evaluating chromatographic purity.

It does not independently demonstrate that the substance has the expected molecular identity, that the entire contents have a particular net peptide mass or that the material is suitable for a proposed biological experiment.

The Food and Drug Administration’s Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients illustrates the importance of connecting analytical records with sample descriptions, batch identifiers, test methods, original measurements and review records. Although that guidance applies to regulated manufacturing activities rather than every research-material transaction, the underlying documentation principles are relevant to laboratory record review.

Researchers unfamiliar with outsourced analysis can benefit from understanding how independent laboratory testing works, particularly the difference between a measurement performed by an outside laboratory and a claim that every characteristic of a material has been verified.

A reliable interpretation begins by asking what the laboratory received, what it measured and which conclusions the recorded evidence can support.

The missing connection between a report and a physical sample

A laboratory may generate a technically sound result for a sample labeled Batch A. Elsewhere, a distributor may hold material identified as Batch B. If the distributor attaches the Batch A report to Batch B without documentation establishing their relationship, the report does not automatically describe the second batch.

This is a hypothetical example, but it exposes a common weakness in documentation review. A valid analytical result is not interchangeable with evidence about every material bearing the same product name.

Peptides can be identified by chemical names, sequences, supplier codes, internal sample numbers and production or packaging batch identifiers. Those labels serve different purposes. The presence of a familiar name on two documents is not sufficient to demonstrate that they refer to the same physical material.

Lot identifiers help connect a received material with records associated with a defined group of material. They are useful only when the organization handling the material maintains that connection accurately.

A researcher reviewing a report should be able to compare the identifier on the physical container with the identifier in the supporting documentation. Where a testing laboratory uses a separate accession number, the accompanying records should make the relationship understandable.

Additional complications arise when a larger batch is repackaged into smaller containers, material is transferred between facilities or a sample is submitted by a party other than the eventual recipient. Those activities do not necessarily invalidate the analysis. They increase the importance of clear records.

The World Health Organization’s 2024 Good Practices for Pharmaceutical Quality Control Laboratories addresses documented sample handling, testing activities and quality systems. Its guidance is written for pharmaceutical quality-control settings, but it provides a useful illustration of why accountability extends beyond a final analytical certificate.

For research procurement, the practical lesson is that the sample-to-report connection should be established before a result is relied upon. A report cannot answer questions about a material that has not been demonstrably connected to the tested sample.

Why a purity percentage is not a complete quality assessment

High-performance liquid chromatography, commonly abbreviated HPLC, separates sample components according to their behavior within a defined analytical system. Depending on the method and detector, the analysis can help identify the presence of different detectable components and estimate their relative contribution to the recorded signal.

In peptide analysis, a reported chromatographic purity percentage is often derived from the area associated with a principal peak relative to the relevant detected peaks. The meaning of that percentage depends on the analytical method and its assumptions.

A dominant peak is not the same as a complete chemical description.

Two compounds can behave similarly under some chromatographic conditions. Certain impurities may not be detected effectively by the selected detector. Different compounds can produce different detector responses, and the method may not account for water, counterions or other material that contributes to total sample mass.

These limitations do not make HPLC unreliable. They mean its results must be interpreted within the method’s demonstrated capabilities.

For example, a report showing 99% chromatographic area associated with a principal peak should not automatically be interpreted as proof that 99% of the dry material’s weight consists of the intended peptide.

The former is a chromatographic measurement. The latter is a statement about material composition that may require additional analytical evidence.

Similarly, HPLC purity data alone cannot demonstrate sterility, verify the absence of every contaminant or establish biological safety. Each question requires an appropriate analytical approach.

Mass spectrometry may provide complementary evidence about molecular mass and identity, depending on the method used and the quality of the resulting data. It does not remove the need for correct sample identification or support conclusions outside its analytical scope.

The distinction is explained in greater detail in this educational discussion of the limitations of HPLC purity testing, including the difference between a chromatographic result and evidence concerning identity, concentration or other characteristics.

A credible report should make the measured property clear. The reader should not have to infer an entire quality assessment from a single headline number.

What the complete analytical record can reveal

A final report is often a condensed presentation of work performed over a longer analytical process. It may show a chromatogram, a result and a brief description of the method without displaying every underlying record.

That abbreviated format is not inherently defective. Different laboratories provide different levels of reporting depending on the purpose, contractual scope and applicable requirements.

Problems arise when a report is represented as definitive evidence while the records needed to understand its generation cannot be explained or, when appropriate, examined.

The FDA’s guidance on data integrity and compliance with current good manufacturing practice discusses electronic audit trails and the ability to reconstruct how analytical records were created or modified. Its separate guidance on laboratory records explains why a printed chromatogram does not necessarily represent the full electronic raw-data record.

In an HPLC system, relevant supporting information can include the analytical method, instrument settings, sample sequence, raw signal, integration settings and records of any subsequent reprocessing.

Integration is especially important. Software may use defined parameters to determine where chromatographic peaks begin and end. Changing those parameters can influence reported peak areas under some circumstances.

That does not mean a revised integration is automatically improper. Analytical data sometimes require justified review or correction. The question is whether changes can be explained, documented and evaluated against the laboratory’s established procedures.

A report reader should also distinguish analytical uncertainty from record uncertainty. The first concerns how confidently a particular property was measured. The second concerns whether the measurements can be connected to the correct sample and reconstructed from reliable records.

Both matter. Excellent instrumental precision cannot compensate for uncertainty about which material was analyzed.

Seven checks before relying on a peptide analysis report

The following questions provide a practical framework for examining documentation without pretending that a certificate alone can establish every property of a research material.

  1. What sample was identified? Compare the reported name, sample code and available chemical identifiers with the material under review.
  2. Which lot was analyzed? Establish whether the report’s lot or batch reference matches the received material, including any documented repackaging relationship.
  3. Who issued the report? Identify the testing organization and distinguish its analytical role from that of the seller or distributor.
  4. When was testing performed? Record the analysis date and consider whether later handling, repackaging or storage introduces questions outside the original test.
  5. Which methods were used? Determine whether the report describes HPLC, mass spectrometry or another technique, and identify the properties those methods measured.
  6. What underlying information is available? Examine the reported findings and supporting data appropriate to the purpose of the review, including chromatograms or spectra when supplied.
  7. What remains unknown? Identify characteristics that were not measured rather than assuming the report establishes them.

When a discrepancy appears, the appropriate response is to resolve the documentation question before treating the analysis as evidence about the material.

USA Peptide Depot has published an educational walkthrough of verifying research-material documentation. It describes how to compare product and lot information, identify the testing laboratory and distinguish reported findings from characteristics outside the test’s scope.

The value of such a process is its repeatability. Different members of a laboratory team should be able to examine the same records and understand how the reported result connects to the material being considered.

Traceability is more demanding than keeping paperwork together

In laboratory discussions, the word traceability sometimes refers to the ability to follow a physical sample through receipt, storage, testing and subsequent handling. That is sample or material traceability.

Metrological traceability has a more specific meaning. The National Institute of Standards and Technology describes it as a property of a measurement result, established through a documented chain of calibrations linked to appropriate references, with uncertainty considered along that chain.

These concepts are related in laboratory quality systems but are not interchangeable.

A laboratory may have excellent records showing who handled a sample while still needing to establish whether a particular quantitative result has the required measurement traceability.

Conversely, a properly calibrated instrument and a documented reference system do not prove that the material submitted for testing was correctly connected to the eventual recipient’s container.

This is why the phrase “traceable testing” deserves careful interpretation. It may refer to instrument calibration, reference standards, sample history or several different processes.

A researcher should ask which kind of traceability the documentation actually demonstrates.

The same discipline applies to laboratory accreditation. An accreditation can provide important information about an organization’s assessed technical competence for particular activities, but its exact scope matters. The presence of a laboratory credential does not automatically extend every method or every reported claim beyond the activities covered by that credential.

Quality evidence is strongest when responsibilities, methods and records are specific rather than described through broad assurances.

Why documentation quality affects reproducibility

Scientific reproducibility depends on understanding what was done and which materials were used. When a repeated experiment produces a different result, researchers may investigate instrument conditions, sample preparation, analytical procedures, experimental design and the materials involved.

If the original material lacks a reliable lot identifier or the analytical documentation cannot be matched to it, an important part of that investigation becomes harder.

The laboratory may be unable to establish whether the later experiment used equivalent material. Investigators can lose time comparing experimental variables while the identity or characteristics of the research input remain uncertain.

This does not mean that every unexpected result comes from material quality. Biological systems are variable, and experimental differences can arise for many reasons. It means incomplete material records introduce an avoidable source of uncertainty.

The benefit of sound documentation becomes particularly apparent when research spans multiple locations or extends over months. Personnel change, records move between systems and remaining samples may be stored separately from the original purchase documents.

A report that can be matched to a defined lot and understood in the context of its analytical method remains more useful than an isolated purity claim.

For laboratories, the most defensible starting point is therefore straightforward: establish the sample’s identity, connect it to the correct analytical record, examine what the method measured and preserve the distinctions between verified findings and unanswered questions.

A convincing certificate is not necessarily a complete certificate. Its scientific value comes from the evidence it contains, the material to which that evidence genuinely applies and the limits that readers are prepared to acknowledge.

Continue Reading

Beauty

Jaw Clicks But Doesn’t Hurt: Ignore It or Get It Looked At?

Published

on

By

A clicking jaw with no pain usually doesn’t call for treatment right away. The click is simply the sound of the disc inside the joint shifting as the jaw opens and closes. Many people live with it for years without it ever becoming a problem. The real decision is whether to keep watching it or mention it at a dental visit.

What’s actually making the sound

The clicking sound has a straightforward mechanical explanation. Understanding it is the first step in knowing whether to just keep watching it or get it looked at. The jaw joint, the temporomandibular joint, sits just in front of each ear and works like a hinge with a small cushioning disc inside it. When that disc slips slightly out of its usual position, it snaps back as the mouth opens wider. That shift produces the pop or click people notice when they yawn, chew, or talk for a while. It’s a mechanical sound, not a sign of damage by itself. A joint can click for years with the disc simply riding a little differently than it used to. The surrounding muscles and ligaments adapt around it, often without ever causing discomfort.

Why no pain changes the calculus

A joint can adapt to a shifted disc without discomfort. Because of that, pain, not the click itself, is usually what turns a joint sound into a problem worth addressing. Clicking alone, without soreness, without the jaw catching or locking, and without morning stiffness, usually means the joint has found a stable way of moving. It’s a slightly unusual pattern, but a stable one. Dentists who see these joints regularly generally don’t treat sound in isolation. Intervening on a joint that isn’t causing trouble can introduce new issues. A bite guard, for example, can change how the teeth meet when nothing needed correcting. For a click without pain, the usual approach is to watch it rather than act on it.

What would move it from “watch” to “check”

Watching is the right call until the picture changes. A few specific developments are worth paying attention to: soreness around the ear or jaw muscles, the jaw catching partway open or closed, and discomfort when chewing tougher foods. Headaches clustering around the temples on the same side as the click are worth noting too. Any of those marks a different picture than sound alone. A bite that suddenly feels off is also worth mentioning at a regular dental visit. So is a sense that the teeth meet differently than they used to. There’s no need to wait for it to resolve on its own. None of these on their own mean something serious is happening, but together they’re the kind of pattern worth having a dentist look at.

What a visit can tell you that waiting can’t

A dental visit exists to sort through exactly those kinds of changes. A dentist examining a clicking jaw checks range of motion and listens for where in the movement the click occurs. They also ask about habits that load the joint, like clenching, teeth grinding, or chewing gum for long stretches. A click that happens early in opening often has a different cause than one that happens near full opening. The two can call for different approaches. That’s why an exam replaces guessing with an actual look at the joint. Farmington patients who want that kind of evaluation can see what’s involved through the TMJ page at MVP Dental. It lays out how the joint is assessed and what options exist if treatment turns out to be warranted. Seeing a dentist about a clicking jaw doesn’t commit anyone to treatment.

The habits that matter regardless

Whether or not a visit ever leads to treatment, a few habits help the joint either way. Cutting back on wide yawns and avoiding all-day gum chewing are reasonable steps for almost anyone. So is noticing whether stress shows up as a clenched jaw during the day. That holds whether the jaw clicks or not. These aren’t fixes in themselves, but they reduce the load on a joint that’s already working a little differently than average. They also cost nothing to try. For a jaw that’s only clicking, that kind of low-effort attention is often enough while the situation is simply being watched.

Making the call

Put together, a click without pain is information, not an emergency. Most people can reasonably choose to keep an eye on it rather than schedule a visit specifically for it. The decision tips toward getting it checked the moment anything else joins the click. That includes discomfort, limited opening, or a change in how the bite feels. Until then, noticing the sound and tracking whether anything changes is a reasonable way to handle it.

Continue Reading
Advertisement

Facebook

Categories

Trending